The effects of transitioning from immediate release to extended release cysteamine therapy in Norwegian patients with nephropathic cystinosis: a retrospective study.

Pediatr Nephrol · 2023 · PMC10514171 · PMID 37219641

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

In line with the short-term real-life study, as well as the approval and follow-up trials [ 6 , 15 , 16 ], the ER-formulation in our study was comparable to the IR-formulation in maintaining the WBC cystine levels in patients with cystinosis, with a slight trend towards a lower percent of cystine levels < 1 nmol during the ER-treatment.

also in 1,639 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.